Literature DB >> 9543324

Clinicopathological features of chronic inflammatory demyelinating polyradiculoneuropathy in childhood.

N Hattori1, M Ichimura, S Aoki, M Nagamatsu, T Yasuda, K Kumazawa, K Yamamoto, T Mitsuma, G Sobue.   

Abstract

The clinical, electrophysiological, and pathological findings, and the therapeutic characteristics in ten children with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), whose onset age was less than 16 years, were evaluated. The clinical progression pattern of the initial phase divided the patients into two groups. One group (six patients) showed a subacute progression for up to 2 months after onset and a subsided progression over 3 months. Three patients in this group had a preceding febrile episode. The other group (four patients) showed a chronic insidious progression for more than 3 months. The former group of patients revealed a favourable response to corticosteroid therapy as compared with the latter group. However, other clinical and laboratory features at the peak impairment were not distinguishable between these two groups. Motor dominant neuropathy was common to all patients, and only three cases showed sensory disturbance on the distal limbs. No cases revealed cranial nerve involvement. Motor and sensory nerve conduction and sural nerve biopsy studies revealed the demyelinating nature of the neuropathy. These clinicopathological features suggest that the subacute progression form frequently associated with prodromal episode and rather favourable corticosteroid response is characteristic in childhood CIDP, while the chronic insidious progression form is indistinguishable from the common adult CIDP.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9543324     DOI: 10.1016/s0022-510x(97)00216-5

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  7 in total

Review 1.  Chronic inflammatory demyelinative polyneuropathy.

Authors:  Gérard Said
Journal:  J Neurol       Date:  2002-03       Impact factor: 4.849

Review 2.  Management of chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  Richard A C Hughes
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 3.  IVIG therapy in neurological disorders of childhood.

Authors:  Juan J Archelos; Franz Fazekas
Journal:  J Neurol       Date:  2006-09       Impact factor: 4.849

Review 4.  Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  Richard Ac Hughes; Man Mohan Mehndiratta; Yusuf A Rajabally
Journal:  Cochrane Database Syst Rev       Date:  2017-11-29

5.  Inflammatory demyelinating neuropathies.

Authors:  Glenn Lopate; Alan Pestronk
Journal:  Curr Treat Options Neurol       Date:  2011-04       Impact factor: 3.972

6.  Autoimmune neuromuscular disorders in childhood.

Authors:  Hugh J McMillan; Basil T Darras; Peter B Kang
Journal:  Curr Treat Options Neurol       Date:  2011-12       Impact factor: 3.598

7.  Pediatric CIDP: Diagnosis and Management. A Single-Center Experience.

Authors:  Małgorzata Łukawska; Anna Potulska-Chromik; Marta Lipowska; Dorota Hoffman-Zacharska; Beata Olchowik; Magdalena Figlerowicz; Karolina Kanabus; Edyta Rosiak; Anna Kostera-Pruszczyk
Journal:  Front Neurol       Date:  2021-07-02       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.